Christian Kcomt
Psychiatry · Wormleysburg, PANPI 1003918087
Payments from drug & device makers
Across 431 payments — averaging $25.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Supernus Pharmaceuticals, Inc.$1K
- Axsome Therapeutics, Inc.$1K
- Takeda Pharmaceuticals U.S.A., Inc.$976
- Johnson & Johnson$953
- Otsuka America Pharmaceutical, Inc.$914
- plus $4K from 17 others
What the payments were for
- Food & beverage$10,930100%
- Education$510%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 88 | $2,103 |
| Supernus Pharmaceuticals, Inc. | 38 | $1,096 |
| Axsome Therapeutics, Inc. | 26 | $1,011 |
| Takeda Pharmaceuticals U.S.A., Inc. | 46 | $976 |
| Johnson & Johnson | 37 | $953 |
| Otsuka America Pharmaceutical, Inc. | 36 | $914 |
| Alkermes, Inc. | 29 | $676 |
| Lundbeck LLC | 26 | $640 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 20 | $600 |
| Corium, LLC | 21 | $528 |
| Ironshore Pharmaceuticals Inc. | 11 | $309 |
| Idorsia Pharmaceuticals US Inc | 14 | $249 |
| E.r. Squibb & Sons, L.L.C. | 8 | $206 |
| Neurocrine Biosciences, Inc. | 6 | $204 |
| Almatica Pharma LLC | 7 | $152 |
| Sunovion Pharmaceuticals Inc. | 8 | $136 |
| Vanda Pharmaceuticals Inc. | 2 | $57 |
| Noven Therapeutics, LLC | 2 | $44 |
| Shire North American Group Inc | 2 | $36 |
| Jazz Pharmaceuticals Inc. | 1 | $26 |
| OWP Pharmaceuticals, Inc. | 1 | $23 |
| Teva Pharmaceuticals USA, Inc. | 1 | $23 |
| Neuronetics, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Auvelity$350
- VRAYLAR$250
- CAPLYTA$125
- SPRAVATO$125
- REXULTI$124
- Azstarys$101
- ABILIFY ASIMTUFII$101
- ABILIFY MAINTENA$101
How this compares
$10,981 in reported general payments places this provider in the 95th percentile of 1,838 psychiatry providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Bupropion XlBupropion Hcl | 41 | $2,330 |
| Aripiprazole | 41 | $2,149 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 18 | $922 |
| Methylphenidate ErMethylphenidate Hcl | 13 | $891 |
| Clonazepam | 53 | $833 |
| Fluoxetine Hcl | 65 | $782 |
| Quetiapine Fumarate | 43 | $615 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 31 | $565 |
| Trazodone Hcl | 43 | $536 |
| Lamotrigine | 26 | $529 |
| Escitalopram Oxalate | 21 | $459 |
| Lorazepam | 39 | $431 |
| Sertraline Hcl | 23 | $416 |
| Mirtazapine | 33 | $380 |
| Ziprasidone Hcl | 13 | $355 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Almatica Pharma LLCSertraline Hcl | $152 | $41623 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,838 psychiatry providers in Pennsylvania.
Other psychiatry in Wormleysburg
- Cherian VergheseNorristown$16.3M
- Steven ArnoldPhiladelphia$4.1M
- Paul GrossAllentown$4.1M
- Shivkumar HattiMedia$4M
- Rebecca RomaPittsburgh$3.3M
- Matthew BergerMoosic$2.4M
- Michael ThasePhiladelphia$2.2M
- Robert NelsonWyomissing$2.2M
- Mark MattaNew Castle$847K
- Mayer AyyashPittsburgh$714K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.